Defining the Therapeutic Range for Adalimumab and Predicting Response in Psoriasis: A Multicenter Prospective Observational Cohort Study

Biologics have transformed management of inflammatory diseases. To optimize outcomes and reduce costs, dose adjustment informed by circulating drug levels has been proposed. We aimed to determine the real-world clinical utility of therapeutic drug monitoring in psoriasis. Within a multicenter (n = 6...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilkinson, Nina, Tsakok, Teresa, Dand, Nick, Bloem, Karien, Duckworth, Michael, Baudry, David, Pushpa-Rajah, Angela, Griffiths, Christopher E.M., Reynolds, Nick J., Barker, Jonathan, Warren, Richard B., Burden, A. David, Rispens, Theo, Stocken, Deborah, Smith, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300405/
https://www.ncbi.nlm.nih.gov/pubmed/30130616
http://dx.doi.org/10.1016/j.jid.2018.07.028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300405/
https://www.ncbi.nlm.nih.gov/pubmed/30130616
http://dx.doi.org/10.1016/j.jid.2018.07.028

Ejemplares similares